Li Qiang, Xing Wanying, Gong Xilong, Wang Yueshu
Department of Hand Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Department of Breast Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Cell Physiol Biochem. 2018;51(3):1149-1163. doi: 10.1159/000495493. Epub 2018 Nov 27.
BACKGROUND/AIMS: Previous studies demonstrated the oncogenic roles of lncRNA UCA1 in osteosarcoma. This study aimed to explore the internal molecular mechanism of UCA1 on promoting osteosarcoma cell proliferation, migration and invasion.
qRT-PCR was conducted to measure the expression levels of UCA1, miR-182 and TIMP2. Cell transfection was used to change the expression levels of UCA1, miR-182 and TIMP2. Cell viability, migration, invasion and apoptosis were measured using CCK-8 assay, two-chamber migration (invasion) assay and Guava Nexin assay, respectively. The associations between UCA1, miR-182 and iASPP were analyzed by dual luciferase activity assay. The protein expression levels of key factors involved in cell apoptosis, PI3K/AKT/GSK3β pathway and NF-κB pathway, as well as p53, Rb, RECQ family and iASPP were evaluated by western blotting.
UCA1 was highly expressed in osteosarcoma MG63 and OS-732 cells. Knockdown of UCA1 inhibited OS-732 cell viability, migration and invasion, but promoted cell apoptosis. miR-182 was up-regulated in OS-732 cells after UCA1 knockdown and participated in the effects of UCA1 on OS-732 cells. TIMP2 was downstream factor of miR-182 and involved in the regulatory roles of miR-182 on OS-732 cell viability, migration, invasion, apoptosis, as well as PI3K/AKT/GSK3β and NF-κB pathways. UCA1 knockdown up-regulated p53, Rb and RECQL5 levels in OS-732 cells, while down-regulated the expression of iASPP. TGF-β or TNF-α treatment could enhance the expression of UCA1 in OS-732 cells.
Our research verified that UCA1 exerted oncogenic roles in osteosarcoma cells by regulating miR-182 and TIMP2, as well as PI3K/AKT/GSK3β and NF-κB pathways.
背景/目的:先前的研究证实了长链非编码RNA UCA1在骨肉瘤中的致癌作用。本研究旨在探讨UCA1促进骨肉瘤细胞增殖、迁移和侵袭的内在分子机制。
采用qRT-PCR检测UCA1、miR-182和TIMP2的表达水平。通过细胞转染改变UCA1、miR-182和TIMP2的表达水平。分别采用CCK-8法、双室迁移(侵袭)法和Guava Nexin法检测细胞活力、迁移、侵袭和凋亡情况。通过双荧光素酶活性测定分析UCA1、miR-182和iASPP之间的关联。采用蛋白质印迹法评估细胞凋亡、PI3K/AKT/GSK3β通路和NF-κB通路相关关键因子以及p53、Rb、RECQ家族和iASPP的蛋白表达水平。
UCA1在骨肉瘤MG63和OS-732细胞中高表达。敲低UCA1可抑制OS-732细胞活力、迁移和侵袭,但促进细胞凋亡。敲低UCA1后,OS-732细胞中miR-182上调,并参与UCA1对OS-732细胞的影响。TIMP2是miR-182的下游因子,参与miR-182对OS-732细胞活力、迁移侵袭、凋亡以及PI3K/AKT/GSK3β和NF-κB通路的调控作用。敲低UCA1可上调OS-732细胞中p53、Rb和RECQ5水平,同时下调iASPP的表达。TGF-β或TNF-α处理可增强OS-732细胞中UCA1表达。
我们的研究证实,UCA1通过调控miR-182和TIMP2以及PI3K/AKT/GSK3β和NF-κB通路在骨肉瘤细胞中发挥致癌作用。